Avanos Medical (NYSE:AVNS – Get Free Report) will post its quarterly earnings results before the market opens on Wednesday, October 30th. Analysts expect Avanos Medical to post earnings of $0.36 per share for the quarter. Avanos Medical has set its FY24 guidance at $1.30-1.45 EPS and its FY 2024 guidance at 1.300-1.450 EPS.Investors that wish to register for the company’s conference call can do so using this link.
Avanos Medical (NYSE:AVNS – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.34 EPS for the quarter, topping the consensus estimate of $0.29 by $0.05. The business had revenue of $171.70 million during the quarter, compared to analyst estimates of $170.67 million. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.24 EPS. On average, analysts expect Avanos Medical to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Avanos Medical Trading Up 1.2 %
Shares of AVNS opened at $22.61 on Tuesday. Avanos Medical has a 1-year low of $17.39 and a 1-year high of $25.36. The company has a current ratio of 2.28, a quick ratio of 1.49 and a debt-to-equity ratio of 0.13. The firm’s 50-day moving average price is $23.44 and its 200-day moving average price is $21.47. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of -17.00 and a beta of 0.91.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Avanos Medical
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
- Five stocks we like better than Avanos Medical
- ETF Screener: Uses and Step-by-Step Guide
- Inflation Trades Gain Momentum: What Investors Should Watch
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Onsemi Stock Is Down, But Not for Long – Is It Time to Buy?
- Trading Halts Explained
- Cigna Considers Humana Acquisition – What It Means for the Stocks
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
